Operating Lease, Payments in GBP of TC BioPharm (Holdings) plc from 2022 to 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
TC BioPharm (Holdings) plc quarterly/annual Operating Lease, Payments history and change rate from 2022 to 2024.
  • TC BioPharm (Holdings) plc Operating Lease, Payments for the quarter ending 31 Mar 2024 was £112K, unchanged year-over-year.
  • TC BioPharm (Holdings) plc annual Operating Lease, Payments for 2024 was £447K, unchanged from 2023.
  • TC BioPharm (Holdings) plc annual Operating Lease, Payments for 2023 was £447K, a 41.5% decline from 2022.
Operating Lease, Payments, Quarterly (GBP)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (GBP)
Operating Lease, Payments, YoY Annual Change (%)

TC BioPharm (Holdings) plc Quarterly Operating Lease, Payments (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 112K 0 0% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q1 2023 112K 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024

TC BioPharm (Holdings) plc Annual Operating Lease, Payments (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 447K 0 0% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025
2023 447K -316K -41.5% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025
2022 763K 01 Jan 2022 31 Dec 2022 20-F 09 May 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.